Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rosmarinic acid + cerium nanoparticles (RA/Ce NPs) is a natural-product-derived catalytic nanoplatform (nanozyme) developed by researchers at Central South University and the University of Wisconsin-Madison. Formed via the self-polymerization of rosmarinic acid in the presence of cerium ions, this hybrid coordination polymer nanosystem is designed to address the dual pathological stressors of excessive reactive oxygen species (ROS) accumulation and persistent tissue hypoxia. The redox-switchable Ce3+/Ce4+ centers within the nanoparticles confer robust superoxide dismutase (SOD)- and catalase (CAT)-mimetic catalytic activities, enabling the efficient scavenging of ROS and the simultaneous generation of oxygen to relieve hypoxia. Additionally, the phenolic-carboxylate-carbonyl framework of the polymerized rosmarinic acid provides abundant coordination sites for radiolabeling (e.g., with zirconium-89), allowing for non-invasive positron emission tomography (PET) imaging-guided therapy. RA/Ce NPs are being investigated for the treatment of acute kidney injury (AKI) and diabetic wound healing, where they demonstrate excellent biocompatibility, renal accumulation, and ROS-responsive biodegradation.
| Indication | Highest phase | Status |
|---|---|---|
| acute kidney injury (AKI) | Preclinical | Active |
| chronic wounds | Preclinical | Active |
| diabetic foot complications | Preclinical | Active |
Every indication, with countries and timelines, is in the full profile.
| Market | Status | Year |
|---|---|---|
| United States | Not approved | — |
| European Union | Not approved | — |
| China | Not approved | — |
| Japan | Not approved | — |
Approved indications and other markets are in the full profile.
Lead indication: acute kidney injury (AKI)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rosmarinic acid + cerium nanoparticles.
Work on rosmarinic acid + cerium nanoparticles? Claim this page to correct or add information. Claim this page